February 20 (SeeNews) - Bulgarian drug maker Sopharma [BUL:SFA] said on Monday that its largest shareholder, diversified group Donev Investments Holding, will increase its direct ownership in the business to 35.24% from 27.89% following the expiry of its tender offer.